Armida Labs Inc.

San Diego, CA

UEI
DXNPA5VKJM96
CAGE
8ZSX3
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Black American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
4845 Tula Ct, San Diego, CA 92122, USA
Website
armida-labs.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Targeting pancreatic cancer metastases with targefrin R44CA277917 National Cancer Institute (NIH) $2,250,000
Targeting pancreatic cancer metastases with targefrin R43CA277917 National Cancer Institute (NIH) $587,500

Similar vendors

Vendor Location Primary NAICS
Primetime Life Sciences, LLC UEI UK3VUKCQM7N4 Germantown, MD 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Epigenetix, Inc. UEI KVPSHD32BK67 Delray Beach, FL 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Phusis Therapeutics, Inc. UEI JGZFBDAL61C4 San Diego, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Tactical Therapeutics, Inc. UEI L1ELDWW9KUL3 New York, NY 325412 Pharmaceutical Preparation Manufacturing
Chrysalis Biotherapeutics, Inc. UEI XW1VFGGRLDW3 Galveston, TX 541714 Research and Development in Biotechnology (except Nanobiotechnology)

See more similar vendors on GovTribe

SBA capabilities narrative

From the vendor's SBA profile

Drug discovery and development in oncology and other disease areas

Quick answers

Is Armida Labs Inc. registered in SAM.gov?

Yes. Armida Labs Inc.'s SAM.gov registration is active through September 28, 2027.

What is Armida Labs Inc.'s most recent federal award?

Armida Labs Inc.'s most recent federal grant award is Targeting pancreatic cancer metastases with targefrin (R44CA277917), from National Cancer Institute (NIH), on April 30, 2024.

On GovTribe

See Armida Labs Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login